Clinical Trial Update: Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of intratumoral DNX-2401 for pediatric high-grade brain tumors is not yet recruiting. The study targets high-grade glioma, ependymoma, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Embryonal Tumor of Brain
• Ependymoma
• High-grade Glioma

Drugs mentioned

• DNX-2401 (Delta-24-RGD)

Snippet

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra | Conditions: High Grade Glioma, Ependymoma | Phase 2 | Status: NOT_YET_RECRUITING